In preparation for CBI’s Abuse Deterrent Formulations Summit, at which Aimed Alliance’s Director of Public Policy, Stacey L. Worthy, will present on May 19, Ms. Worthy participated in a Q&A with the CBI Scene Blog. The back-and-forth conversation touched on issues associated with the nationwide prescription drug abuse epidemic and the FDA’s new final guidance on abuse-deterrent formulations. To read the full Q&A, click here.
Last Updated on April 24, 2020 by Aimed Alliance
